UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 214

Sortiert nach

Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond

Seminars in cancer biology, 2021-07, Vol.72, p.123-135

2021

Volltextzugriff (PDF)

Molecular alterations of neuroendocrine tumours of the lung

Histopathology, 2018-01, Vol.72 (1), p.142-152

2018

Volltextzugriff (PDF)

Distinctive pathological and clinical features of lung carcinoids with high proliferation index

Virchows Archiv : an international journal of pathology, 2017-12, Vol.471 (6), p.713-720

2017

Volltextzugriff (PDF)

The Multifaceted Nature of Tumor Microenvironment in Breast Carcinomas

Pathobiology (Basel), 2020-05, Vol.87 (2), p.125

2020

Volltextzugriff (PDF)

FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer

Cancer research (Chicago, Ill.), 2010-03, Vol.70 (5), p.2085-2094

2010

Volltextzugriff (PDF)

Tissues under-vacuum to overcome suboptimal preservation

New biotechnology, 2019-09, Vol.52, p.104-109

2019

Volltextzugriff (PDF)

BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS-Mutant Colorectal Cancer

Clinical cancer research, 2016-10, Vol.22 (19), p.4923-4933

2016

Volltextzugriff (PDF)

Navigating practical challenges in immunotherapy for metastatic triple negative breast cancer

Cancer treatment reviews, 2024-07, Vol.128, p.102762-102762, Article 102762

2024

Volltextzugriff (PDF)

Adenoid cystic carcinomas of the breast and salivary glands (or ‘The strange case of Dr Jekyll and Mr Hyde’ of exocrine gland carcinomas)

Journal of Clinical Pathology, 2010-03, Vol.63 (3), p.220-228

2010

Volltextzugriff (PDF)

Synthetic Lethal Interaction with BCL-XL Blockade Deepens Response to Cetuximab in Patient-Derived Models of Metastatic Colorectal Cancer

Clinical cancer research, 2023-03, Vol.29 (6), p.1102-1113

2023

Volltextzugriff (PDF)

SF3B1 mutations constitute a novel therapeutic target in breast cancer

The Journal of pathology, 2015-03, Vol.235 (4), p.571-580

2015

Volltextzugriff (PDF)

Unique Patterns of Heterogeneous Mismatch Repair Protein Expression in Colorectal Cancer Unveil Different Degrees of Tumor Mutational Burden and Distinct Tumor Microenvironment Features

Modern pathology, 2023-02, Vol.36 (2), p.100012-100012, Article 100012

2023

Volltextzugriff (PDF)

Mitotic Spindle Assembly and Genomic Stability in Breast Cancer Require PI3K-C2α Scaffolding Function

Cancer cell, 2017-10, Vol.32 (4), p.444-459.e7

2017

Volltextzugriff (PDF)

Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs)

Virchows Archiv : an international journal of pathology, 2023-03, Vol.482 (3), p.463-475

2023

Volltextzugriff (PDF)

"Borderline" epithelial lesions of the breast: what have we learned in the past three decades?

Pathologica, 2021-10, Vol.113 (5), p.354-359

2021

Volltextzugriff (PDF)

Tissue Fixation with a Formic Acid-Deprived Formalin Better Preserves DNA Integrity over Time

Pathobiology (Basel), 2023-06, Vol.90 (3), p.155

2023

Volltextzugriff (PDF)

Lobular Breast Cancer: Histomorphology and Different Concepts of a Special Spectrum of Tumors

Cancers, 2021-07, Vol.13 (15), p.3695

2021

Volltextzugriff (PDF)

TROP2, androgen receptor, and PD‐L1 status in histological subtypes of high‐grade metaplastic breast carcinomas

Histopathology, 2023-04, Vol.82 (5), p.664-671

2023

Volltextzugriff (PDF)

Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants

NPJ breast cancer, 2016-11, Vol.2 (1), p.16036-16036, Article 16036

2016

Volltextzugriff (PDF)

Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance

Cancer cell, 2023-01, Vol.41 (1), p.196-209.e5

2023

Volltextzugriff (PDF)

HER2 Copy Number and Resistance Mechanisms in Patients with HER2-positive Advanced Gastric Cancer Receiving Initial Trastuzumab-based Therapy in JACOB Trial

Clinical cancer research, 2023-02, Vol.29 (3), p.571-580

2023

Volltextzugriff (PDF)

Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast

Modern pathology, 2018-01, Vol.31 (1), p.68-82

2018

Volltextzugriff (PDF)

Special Issue: Molecular Biomarkers in Solid Tumors

Genes, 2021-06, Vol.12 (7), p.984

2021

Volltextzugriff (PDF)

1 – 25 von 214

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(197)
Mit Volltextzugriff
(206)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(16)
Histopathology
(13)
Cancers
(11)
The Journal Of Pathology
(10)
Clinical Cancer Research
(8)
Journal Of Pathology
(8)
Modern Pathology
(8)
Virchows Archiv : An International Journal Of Pathology
(8)
Virchows Archiv
(6)
Frontiers In Oncology
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond

Molecular alterations of neuroendocrine tumours of the lung

Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial

Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations

Distinctive pathological and clinical features of lung carcinoids with high proliferation index

The Multifaceted Nature of Tumor Microenvironment in Breast Carcinomas

FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer

Tissues under-vacuum to overcome suboptimal preservation

BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS-Mutant Colorectal Cancer

Navigating practical challenges in immunotherapy for metastatic triple negative breast cancer

Adenoid cystic carcinomas of the breast and salivary glands (or ‘The strange case of Dr Jekyll and Mr Hyde’ of exocrine gland carcinomas)

Synthetic Lethal Interaction with BCL-XL Blockade Deepens Response to Cetuximab in Patient-Derived Models of Metastatic Colorectal Cancer

SF3B1 mutations constitute a novel therapeutic target in breast cancer

Unique Patterns of Heterogeneous Mismatch Repair Protein Expression in Colorectal Cancer Unveil Different Degrees of Tumor Mutational Burden and Distinct Tumor Microenvironment Features

Mitotic Spindle Assembly and Genomic Stability in Breast Cancer Require PI3K-C2α Scaffolding Function

Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs)

"Borderline" epithelial lesions of the breast: what have we learned in the past three decades?

Tissue Fixation with a Formic Acid-Deprived Formalin Better Preserves DNA Integrity over Time

Lobular Breast Cancer: Histomorphology and Different Concepts of a Special Spectrum of Tumors

TROP2, androgen receptor, and PD‐L1 status in histological subtypes of high‐grade metaplastic breast carcinomas

Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants

Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance

HER2 Copy Number and Resistance Mechanisms in Patients with HER2-positive Advanced Gastric Cancer Receiving Initial Trastuzumab-based Therapy in JACOB Trial

Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast

Special Issue: Molecular Biomarkers in Solid Tumors

Suchergebnisse filtern